Market Insights Health Hospitals Inpatient Care

Gastroenterology - Australia

Australia

In Australia, the revenue in the Gastroenterology market is forecasted to reach AU €2.71bn in 2024.
It is expected to exhibit an annual growth rate (CAGR 2024-2029) of 3.76%, leading to a market volume of AU €3.26bn by 2029.
When compared globally, United States is projected to generate the highest revenue, amounting to €56,090.00m in 2024.
Despite being a developed country, Australia still faces challenges in providing equitable access to gastroenterology services across its vast and geographically diverse regions.

Key regions: France, China, Japan, United States, Europe

Mercado

Región

Comparación de regiones

Moneda

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.